Tiger Brokers

Weigao Group Buys Back 300,000 H-Shares, Lifts Treasury Stock to 50.07 Million

Bulletin Express
Apr 09

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed a share repurchase executed on 09 April 2026 under its existing mandate.

• Transaction details – Volume: 300,000 H-shares – Price range: HKD 3.70–3.77; volume-weighted average HKD 3.7347 – Consideration: HKD 1.12 million

• Capital structure after the buyback – Issued shares (ex-treasury): 4.47227 billion, down 300,000 shares (-0.0067%) – Treasury shares: 50.07 million – Total issued shares unchanged at 4.52233 billion

• Repurchase mandate utilisation – Mandate authorised on 27 May 2025 for up to 451.56 million shares – Cumulative repurchases under the mandate: 43.42 million shares, representing 9.61% of the authorised limit

• Moratorium – In line with Hong Kong listing rules, no new share issue or treasury-share sale is permitted until 10 May 2026.

All procedures were confirmed compliant with Hong Kong Main Board rules and relevant legal requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10